On-embryo transfer patients. Fertil Steril 2004, 81(3):562?66. 32. Kolibianakis EM, Zikopoulos K, Smitz J
On-embryo transfer patients. Fertil Steril 2004, 81(3):562?66. 32. Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC: Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization. Fertil Steril 2004, 82(1):223?26. 33. C rin-Durnerin I: Antagonist protocols: residual LH levels and the value of exogenous LH supplementation. J Gynecol Obstet Biol Reprod (Paris) 2004, 33(6 Pt 2):3S29?S31.Depalo et al. Reproductive Biology and Endocrinology 2012, 10:26 http://www.rbej.com/content/10/1/Page 8 of34. C rin-Durnerin I, Grange-Dujardin D, PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27766426 Laffy A, Parneix I, Massin N, Galey J, Th on L, Wolf JP, Conord C, Cl ent P, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28499442 Jayot S, Hugues JN: Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI Z-DEVD-FMK manufacturer cycles: a prospective randomized study. Hum Reprod 2004, 19 (9):1979?984. 35. Aboulghar MA, Mansour RT, Serour GI, Al-Inany HG, Amin YM, Aboulghar MM: Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial. Reprod Biomed Online 2004, 8(5):524?27. 36. Merviel P, Antoine JM, Mathieu E, Millot F, Mandelbaum J, Uzan S: Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer. Fertil Steril 2004, 82(1):119?25. 37. Baruffi RL, Mauri AL, Petersen CG, Felipe V, Martins AM, Cornicelli J, Cavagna M, Oliveira JB, Franco JG Jr: Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis. Reprod Biomed Online 2007, 14 (1):14?5. 38. Huirne JA, van Loenen AC, Schats R, McDonnell J, Hompes PG, Schoemaker J, Homburg R, Lambalk CB: Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod 2005, 20(2):359?67. 39. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G: Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006, 12(6):651?71. 40. Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B: Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril 2010, 94(6):2382?384. 41. Kosmas IP, Zikopoulos K, Gorgiou I, Paraskevaidis E, Blockeel C, Tournaye H, Van Der Elst J, Devroey P: Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis. Reprod Biomed Online 2009, 19(5):619?30. 42. European and Middle East Orgalutran Study Group: Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001, 16(4):644?51. 43. Huirne JA, Lambalk CB: Gonadotropin-releasing-hormone-receptor antagonists. Lancet 2001, 358(9295):1793?803. 44. Engel JB, Griesinger G, Schultze-Mosgau A, Felberbaum R, Diedrich K: GnRH agonists and antagonists in assisted reproduction: pregnancy rate. Reprod Biomed Online 2006, 13(1):84?7. 45. Depalo R, Lorusso F, Palmisano M, Bassi E, Totaro I, Vacca M, et al: Follicular growth and oocyte maturation in Gn.